Heparitin Sulfate

alpha-L-iduronidase ; Homo sapiens







39 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33572941 Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement. 2021 Jan 29 1
2 34360653 Differences in MPS I and MPS II Disease Manifestations. 2021 Jul 23 3
3 32154058 Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha-L-iduronidase determinations on dried blood spots to predict symptoms. 2020 Mar 1
4 32188113 Mucopolysaccharidosis Type I. 2020 Mar 16 1
5 33073008 Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I. 2020 Mar 2
6 31544795 A novel compound mutation in alpha-L-iduronidase gene causes mucopolysaccharidosis type I. 2019 Sep 1
7 30081189 CRISPR-Cas9-mediated gene editing in human MPS I fibroblasts. 2018 Dec 15 1
8 24368159 Neurocognitive and neuropsychiatric phenotypes associated with the mutation L238Q of the α-L-iduronidase gene in Hurler-Scheie syndrome. 2014 Feb 1
9 24483599 Hematopoietic stem cell transplantation effects on spinal cord compression in Hurler. 2014 May 2
10 25359774 Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I. 2014 Dec 26 2
11 25459762 Lessons from molecular modeling human α-L-iduronidase. 2014 Nov 4
12 25558755 Mutation c.1190-1delG/N in intron 8 and c.1708G>C/N in exon 12 not reported in the IDUA gene developed a clinical phenotype of Scheie syndrome. 2014 Dec 1
13 27896125 Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru. 2014 2
14 27326280 Mucopolysaccharidosis type I Hurler-Scheie syndrome affecting two sisters. 2012 1
15 21521498 Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms. 2011 Apr 26 2
16 22074387 Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population. 2011 Nov 10 1
17 19839758 Mutational Analysis of the alpha-L-iduronidase gene in three Egyptian families: identification of three novel mutations and five novel polymorphisms. 2009 Dec 2
18 15639191 Prediction of neuropathology in mucopolysaccharidosis I patients. 2005 Jan 1
19 15947088 Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells. 2005 Sep 15 2
20 14718373 Glycosaminoglycan degradation fragments in mucopolysaccharidosis I. 2004 May 1
21 11861306 Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type I. 2002 Mar 1 1
22 11735025 Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations. 2001 Nov 1
23 9725536 Endoscopic adenoidectomy in a case of Scheie syndrome (MPS I S). 1998 Jul 10 1
24 9425437 Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts. 1997 Nov 2
25 8680403 Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications. 1995 2
26 7998955 Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts. 1994 Nov 15 4
27 1301196 A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype. 1992 1
28 1301941 alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype. 1992 1
29 1505961 Structure and sequence of the human alpha-L-iduronidase gene. 1992 Aug 2
30 1550122 Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients. 1992 Apr 1
31 1554373 Human alpha-L-iduronidase. Catalytic properties and an integrated role in the lysosomal degradation of heparan sulphate. 1992 Mar 15 1
32 1917344 Airway obstruction in Hurler's syndrome--radiographic features. 1991 Jul 1
33 1946389 Human alpha-L-iduronidase: cDNA isolation and expression. 1991 Nov 1 2
34 2220820 Chromosomal localization of the human alpha-L-iduronidase gene (IDUA) to 4p16.3. 1990 Nov 2
35 2470345 Immunopurification and characterization of human alpha-L-iduronidase with the use of monoclonal antibodies. 1989 Apr 1 1
36 6231139 Heparan sulfate and dermatan sulfate from the liver of a patient with Hurler syndrome: high performance liquid chromatography of their degradation products after incubation with alpha-L-iduronidase-deficient fibroblasts. 1984 Feb 28 1
37 161508 Structure of heparan sulphate oligosaccharides and their degradation by exo-enzymes. 1979 Dec 1 1
38 102641 Fluorometric measurement of urinary alpha-L-iduronidase activity. 1978 Sep 1
39 154210 [Mucopolysaccharidosis V (Ullrich-Scheie syndrome) (author's transl)]. 1978 Dec 8 1